Oxidative challenge in Alzheimer's disease: state of knowledge and future needs

Free radicals and antioxidants in normal physiological functions and human disease

Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269 · see citing works

Superoxide Dismutase

McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952 · see citing works

Mild cognitive impairment as a diagnostic entity

Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864 · see citing works

Alzheimer's disease: the amyloid cascade hypothesis

Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · see citing works

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease

Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155 · see citing works

Metals, Toxicity and Oxidative Stress

Valko, M., Morris, H., & Cronin, M. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053764635 · Cited by 5,018 · see citing works

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806 · see citing works

Oxidative stress: oxidants and antioxidants

Sies, H. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004024 · Cited by 4,577 · see citing works

Neurodegenerative diseases and oxidative stress

Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · see citing works

Neuropathological alterations in Alzheimer disease

Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · see citing works

Mitochondrial free radical generation, oxidative stress, and aging

Cadenas, E., & Davies, K. J. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00317-8 · Cited by 3,010 · see citing works

Reactive oxygen species in cell signaling

Thannickal, V. J., & Fanburg, B. L. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1005 · Cited by 2,936 · see citing works

Oxidative stress hypothesis in Alzheimer’s disease

Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383 · see citing works

Invited review: Oxidation of biological systems: Oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification

Kohen, R., & Nyska, A. (2002) · Toxicologic Pathology · doi:10.1080/01926230290166724 · Cited by 2,178 · see citing works

Oxyradicals and DNA damage

Marnett, L. J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.361 · Cited by 1,887 · see citing works

8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions.

Cheng, K. C., Cahill, D. S., Kasai, H., Nishimura, S., & Loeb, L. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48474-8 · Cited by 1,844 · see citing works

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844 · see citing works

Biomarkers of Oxidative Damage in Human Disease

Dalle-Donne, I., Rossi, R., Colombo, R., Giustarini, D., & Milzani, A. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.061408 · Cited by 1,703 · see citing works

Role of oxidative stress in cardiovascular diseases

Dhalla, N. S., Temsah, R. M., & Netticadan, T. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018060-00002 · Cited by 1,467 · see citing works

Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study

Keaney, J. F., Larson, M. G., Vasan, R. S., Wilson, P. W. F., Lipinska, I., Corey, D., Massaro, J. M., Sutherland, P., Vita, J. A., & Benjamin, E. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000058402.34138.11 · Cited by 1,304 · see citing works

Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease

Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239 · see citing works

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Aviram, M., Rosenblat, M., Bisgaier, C. L., Newton, R. S., Primo-Parmo, S. L., & Du, B. N. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1649 · Cited by 1,167 · see citing works

Dietary Intake of Antioxidants and Risk of Alzheimer Disease

Engelhart, M. J. (2002) · JAMA · doi:10.1001/jama.287.24.3223 · Cited by 1,080 · see citing works

Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease

Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037 · see citing works

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD

Jack, C. R., Petersen, R. C., Xu, Y., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Tangalos, E. G., & Kokmen, E. (2000) · Neurology · doi:10.1212/wnl.55.4.484 · Cited by 937 · see citing works

Visceral and Subcutaneous Adipose Tissue Volumes Are Cross-Sectionally Related to Markers of Inflammation and Oxidative Stress

Pou, K. M., Massaro, J. M., Hoffmann, U., Vasan, R. S., Maurovich‐Horvat, P., Larson, M. G., Keaney, J. F., Meigs, J. B., Lipinska, I., Kathiresan, S., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.710509 · Cited by 898 · see citing works

Oxidative Stress and the Pathogenesis of Alzheimer's Disease

Zhao, Y., & Zhao, B. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/316523 · Cited by 855 · see citing works

Biomarkers of free radical damage

de Zwart, L. L., Meerman, J. H. N., Commandeur, J. N. M., & Vermeulen, N. P. E. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00196-8 · Cited by 837 · see citing works

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics

de la Torre, J. C. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00683-0 · Cited by 834 · see citing works

Biological markers of oxidative stress: Applications to cardiovascular research and practice

Ho, E. C., Galougahi, K. K., Liu, C., Bhindi, R., & Figtree, G. A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.07.006 · Cited by 812 · see citing works

Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study

Ott, A., Breteler, M. M. B., van Harskamp, F., Claus, J. J., van der Cammen, T. J. M., Grobbee, D. E., & Hofman, A. (1995) · BMJ · doi:10.1136/bmj.310.6985.970 · Cited by 792 · see citing works

Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis

Praticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04183.2001 · Cited by 777 · see citing works

A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease

Swerdlow, R. H., & Khan, S. M. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.045 · Cited by 758 · see citing works

How do nutritional antioxidants really work: Nucleophilic tone and para-hormesis versus free radical scavenging in vivo

Forman, H. J., Davies, K. J. A., & Ursini, F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.045 · Cited by 707 · see citing works

Biomarkers of Oxidative Stress Study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?

Kadiiska, M. B., Gladen, B. C., Baird, D. D., Germolec, D. R., Graham, L., Parker, C. E., Nyska, A., Wachsman, J. T., Ames, B. N., Basu, S., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.017 · Cited by 699 · see citing works

GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration

Winkler, E. A., Nishida, Y., Sagare, A. P., Rege, S. V., Bell, R. D., Perlmutter, D., Sengillo, J. D., Hillman, S., Kong, P., Nelson, A. R., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3966 · Cited by 689 · see citing works

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease

Markesbery, W. R., & Lovell, M. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00009-8 · Cited by 680 · see citing works

Oxygen, Reactive Oxygen Species and Tissue Damage

Bergamini, C. M., Gambetti, S., Dondi, A., & Cervellati, C. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384664 · Cited by 661 · see citing works

Intake of flavonoids and risk of dementia

Commenges, D., Scotet, V., Renaud, S., Jacqmin‐Gadda, H., Barberger‐Gateau, P., & Dartigues, J. (2000) · European Journal of Epidemiology · doi:10.1023/a:1007614613771 · Cited by 647 · see citing works

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

Lovell, M. A., Ehmann, W. D., Butler, S. M., & Markesbery, W. R. (1995) · Neurology · doi:10.1212/wnl.45.8.1594 · Cited by 644 · see citing works

β-Amyloid Peptides Induce Mitochondrial Dysfunction and Oxidative Stress in Astrocytes and Death of Neurons through Activation of NADPH Oxidase

Abramov, A. Y., Canevari, L., & Duchen, M. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4042-03.2004 · Cited by 587 · see citing works

Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI☆

MISRA, C., FAN, Y., & DAVATZIKOS, C. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.10.031 · Cited by 552 · see citing works

Evidence of increased oxidative damage in subjects with mild cognitive impairment

Keller, J. N., Schmitt, F. A., Scheff, S. W., Ding, Q., Chen, Q., Butterfield, D. A., & Markesbery, W. R. (2005) · Neurology · doi:10.1212/01.wnl.0000156156.13641.ba · Cited by 539 · see citing works

Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity With Systemic Oxidative Stress and Cardiovascular Risk

Bhattacharyya, T. (2008) · JAMA · doi:10.1001/jama.299.11.1265 · Cited by 535 · see citing works

Amyloid <i>β</i> -Peptide (1–42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression

Butterfield, D. A., Swomley, A. M., & Sultana, R. (2013) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2012.5027 · Cited by 526 · see citing works

Oxidative stress in Alzheimer disease: A possibility for prevention

Bonda, D., Wang, X., Perry, G. L., Nunomura, A., Tabaton, M., Zhu, X., & Smith, M. A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.005 · Cited by 481 · see citing works

MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease ☆ ☆This research was supported by grants P01 AG09466 and P30 AG10161 from the National Institute on Aging, National Institutes of Health.

Dickerson, B. C., Goncharova, I. I., Sullivan, M., Forchetti, C., Wilson, R. S., Bennett, D. A., Beckett, L. A., & deToledo‐Morrell, L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00271-8 · Cited by 481 · see citing works

Lipid peroxidation triggers neurodegeneration: A redox proteomics view into the Alzheimer disease brain

Sultana, R., Perluigi, M., & Butterfield, D. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.027 · Cited by 478 · see citing works

Factors Associated with Oxidative Stress in Human Populations

Block, G. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf029 · Cited by 470 · see citing works

Use of Biomarkers and Surrogate Endpoints in Drug Development and Regulatory Decision Making: Criteria, Validation, Strategies

Lesko, L., & Atkinson, A. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.347 · Cited by 465 · see citing works

Stable markers of oxidant damage to proteins and their application in the study of human disease

Davies, M. J., Fu, S., Wang, H., & Dean, R. T. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00206-3 · Cited by 461 · see citing works

Neuropathologic Substrate of Mild Cognitive Impairment

Markesbery, W. R., Schmitt, F. A., Kryscio, R. J., Davis, D. G., Smith, C. D., & Wekstein, D. R. (2006) · Archives of Neurology · doi:10.1001/archneur.63.1.38 · Cited by 460 · see citing works

Alzheimer’s disease pathogenesis and therapeutic interventions

Parihar, M. S., & Hemnani, T. (2004) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2003.12.007 · Cited by 434 · see citing works

Formation of Isoprostane-like Compounds (Neuroprostanes) in Vivo from Docosahexaenoic Acid*

Roberts, L., Montine, T., Markesbery, W., Tapper, A. R., Hardy, P., Chemtob, S., Dettbarn, W., & Morrow, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13605 · Cited by 430 · see citing works

Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis

Shih, D. M., Xia, Y.-R., Wang, X.-P., Miller, E. R., Castellani, L. W., Subbanagounder, G., Cheroutre, H., Faull, K. F., Berliner, J. A., Witztum, J. L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910376199 · Cited by 423 · see citing works

Vitamin E for Alzheimer's dementia and mild cognitive impairment

Farina, N., Llewellyn, D. J., Isaac, M. G. E. K. N., & Tabet, N. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002854.pub5 · Cited by 421 · see citing works

Antioxidant Vitamin Intake and Risk of Alzheimer Disease

Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.203 · Cited by 414 · see citing works

Increased F ₂ ‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation <i>in vivo</i>

Pratico, D., Lee, V. M.-Y., Trojanowski, J. Q., Rokach, J., & Fitzgerald, G. A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1777 · Cited by 405 · see citing works

MRI and CSF biomarkers in normal, MCI, and AD subjects

Vemuri, P., Wiste, H. J., Weigand, S. D., Shaw, L. M. J., Trojanowski, J. Q., Weiner, M. W., Knopman, D. S., Petersen, R. C., & Jack, C. R. (2009) · Neurology · doi:10.1212/wnl.0b013e3181af79fb · Cited by 398 · see citing works

Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: Protection against reactive oxygen and nitrogen species‐induced cell injury

Zhu, H., Itoh, K., Yamamoto, M. P., Zweier, J. L., & Li, Y. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.058 · Cited by 394 · see citing works

Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc

Cuajungco, M. P., Goldstein, L. E., Nunomura, A., Smith, M. A., Lim, J. T., Atwood, C., Huang, X., Farrag, Y. W., Perry, G. L., & Bush, A. I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000165200 · Cited by 392 · see citing works

Oxidation of LDL by Myeloperoxidase and Reactive Nitrogen Species

Carr, A. C., McCall, M. R., & Frei, B. B. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.7.1716 · Cited by 392 · see citing works

Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease

Butterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377 · see citing works

Progress Towards the Discovery of Xanthine Oxidase Inhibitors

Borges, F., Fernandes, E. G. R., & Roleira, F. M. F. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023371229 · Cited by 373 · see citing works

Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils

Carreras, M. C., Pargament, G. A., Catz, S. D., Poderoso, J. J., & Boveris, A. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80241-6 · Cited by 364 · see citing works

Correlates of Markers of Oxidative Status in the General Population

Trevisan, M. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.4.348 · Cited by 351 · see citing works

Oxidative stress and aging: beyond correlation

Golden, T. R., Hinerfeld, D. A., & Melov, S. (2002) · Aging Cell · doi:10.1046/j.1474-9728.2002.00015.x · Cited by 343 · see citing works

Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis

Schrag, M., Mueller, C., Zabel, M. K., Crofton, A. R., Kirsch, W. M., Ghribi, O., Squitti, R., & Perry, G. L. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.07.005 · Cited by 335 · see citing works

Oxidative stress mediates tau-induced neurodegeneration in Drosophila

Dias-Santagata, D., Fulga, T. A., Duttaroy, A., & Feany, M. B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28769 · Cited by 318 · see citing works

The Revitalized Tau Hypothesis on Alzheimer's Disease

Maccioni, R. B., Farias, G. A., Morales, I., & Navarrete, L. P. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.03.007 · Cited by 316 · see citing works

Evidence of Oxidative Stress in Alzheimer's Disease Brain and Antioxidant Therapy

Praticò, D. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.010 · Cited by 315 · see citing works

Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: Implications for early intervention and therapeutics

Mao, P., & Reddy, P. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.08.005 · Cited by 311 · see citing works

Even free radicals should follow some rules: A Guide to free radical research terminology and methodology

Forman, H. J., Augusto, O., Brigelius‐Flohé, R., Dennery, P. A., Kalyanaraman, B., Ischiropoulos, H., Mann, G. E., Radí, R., Roberts, L. J., Viña, J., et al. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.10.504 · Cited by 303 · see citing works

Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change

Morris, M. C., Evans, D. A., Tangney, C. C., Bienias, J. L., Wilson, R. S., Aggarwal, N. T., & Scherr, P. A. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn.81.2.508 · Cited by 302 · see citing works

Oxidative stress and β-amyloid protein in Alzheimer’s disease

Cai, Z., Zhao, B., & Ratka, A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8155-9 · Cited by 279 · see citing works

Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment

Markesbery, W. R., Kryscio, R. J., Lovell, M. A., & Morrow, J. D. (2005) · Annals of Neurology · doi:10.1002/ana.20629 · Cited by 272 · see citing works

Elevated Serum Pesticide Levels and Risk for Alzheimer Disease

Richardson, J. R., Roy, A., Shalat, S. L., von Stein, R. T., Hossain, M. M., Buckley, B., Gearing, M., Levey, A. I., & German, D. C. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6030 · Cited by 263 · see citing works

Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment

Wang, J., Markesbery, W. R., & Lovell, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03615.x · Cited by 260 · see citing works

Cerebrospinal fluid F2‐isoprostane levels are increased in Alzheimer's disease

Montine, T., Markesbery, W., Morrow, J., & Roberts, L. (1998) · Annals of Neurology · doi:10.1002/ana.410440322 · Cited by 254 · see citing works

Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde

McGrath, L. T. (2001) · QJM · doi:10.1093/qjmed/94.9.485 · Cited by 253 · see citing works

Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment

Mangialasche, F., Polidori, M. C., Monastero, R., Ercolani, S., Camarda, C., Cecchetti, R., & Mecocci, P. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.04.002 · Cited by 247 · see citing works

Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment

Butterfield, D. A., Reed, T., Perluigi, M., De Marco, C., Coccia, R., Cini, C., & Sultana, R. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.017 · Cited by 246 · see citing works

Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases

Montine, K. S., Quinn, J. F., Zhang, J., Fessel, J. P., Roberts, L. J., Morrow, J. D., & Montine, T. J. (2003) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2003.10.010 · Cited by 242 · see citing works

Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: Implications for the role of nitration in the progression of Alzheimer's disease

Butterfield, D. A., Reed, T. T., Marzia Perluigi, A., Marco, C. M. D., Coccia, R., Keller, J. N., Markesbery, W. R., & Rukhsana Sultana, A. (2007) · Brain Research · doi:10.1016/j.brainres.2007.02.084 · Cited by 238 · see citing works

Pathogenesis of Alzheimer's disease.

Swerdlow, R. H. (2007) · PubMed Central · Cited by 236 · see citing works

Elevation of serum copper levels in Alzheimer’s disease

Squitti, R., Lupoi, D., Pasqualetti, P., Forno, G. D., Vernieri, F., Chiovenda, P., Rossi, L. C., Cortesi, M., Cassetta, E., & Rossini, P. M. (2002) · Neurology · doi:10.1212/wnl.59.8.1153 · Cited by 236 · see citing works

Peripheral Oxidative Stress Biomarkers in Mild Cognitive Impairment and Alzheimer's Disease

Torres, L. H., Quaglio, N. B., de Souza, G. T., Garcia, R. C. T., Dati, L. M. M., Moreira, W. L., Loureiro, A. P. D. M., Souza‐Talarico, J. N., Smid, J., Porto, C. S., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110284 · Cited by 235 · see citing works

The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease.

Wilkinson, B. L., & Landreth, G. E. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-30 · Cited by 235 · see citing works

Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress

LI, Y., Cao, Z., & Zhu, H. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.08.002 · Cited by 235 · see citing works

Plasma cytokines profile in older subjects with late onset Alzheimer’s disease or vascular dementia

Zuliani, G., Ranzini, M., Guerra, G., Rossi, L., Munari, M. R., Zurlo, A., Volpato, S., Atti, A. R., Blè, A., & Fellin, R. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.02.008 · Cited by 234 · see citing works

Oxidative Stress and Blood–Brain Barrier Dysfunction Under Particular Consideration of Matrix Metalloproteinases

Lehner, C., Gehwolf, R., Tempfer, H., Krizbai, I. A., Hennig, B., Bauer, H., & Bauer, H. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3923 · Cited by 231 · see citing works

Assay of Aldehydes from Lipid Peroxidation: Gas Chromatography–Mass Spectrometry Compared to Thiobarbituric Acid

Liu, J., Yeo, H. C. H., Doniger, S. J., & Ames, B. N. (1997) · Analytical Biochemistry · doi:10.1006/abio.1996.9990 · Cited by 229 · see citing works

Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease

Mecocci, P. (2002) · Archives of Neurology · doi:10.1001/archneur.59.5.794 · Cited by 229 · see citing works

Nitrosative Stress, Cellular Stress Response, and Thiol Homeostasis in Patients with Alzheimer's Disease

Calabrese, V., Rukhsana Sultana, A., Scapagnini, G., Guagliano, E., Sapienza, M. A., Bella, R., Kański, J., Pennisi, G., Mancuso, C., Stella, A. M. G., et al. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1975 · Cited by 227 · see citing works

Is Alzheimer’s disease a systemic disease?

Morris, J. K., Honea, R. A., Vidoni, E. D., Swerdlow, R. H., & Burns, J. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.012 · Cited by 219 · see citing works

Basic mechanisms of antioxidant activity

Cadenas, E. (1997) · BioFactors · doi:10.1002/biof.5520060404 · Cited by 203 · see citing works

Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup

Sperling, R. A., Aisen, P. S. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J. A., Montine, T. J., et al. (2011) · Cited by 197 · see citing works

Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: The hunt goes on

Costa, L. G., Giordano, G., & Furlong, C. E. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.11.008 · Cited by 188 · see citing works

A specific, accurate, and sensitive measure of total plasma malondialdehyde by HPLC

Moselhy, H. F., Reid, R. G., Yousef, S., & Boyle, S. P. (2012) · Journal of Lipid Research · doi:10.1194/jlr.d032698 · Cited by 188 · see citing works

Copper in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies

Bucossi, S., Ventriglia, M., Panetta, V., Salustri, C., Pasqualetti, P., Mariani, S., Siotto, M., Rossini, P. M., & Squitti, R. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101473 · Cited by 183 · see citing works

Copper in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies

Ventriglia, M., Bucossi, S., Panetta, V., & Squitti, R. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120244 · Cited by 180 · see citing works

Mass spectrometry for detection of 4‐hydroxy‐trans‐2‐nonenal (HNE) adducts with peptides and proteins

Carini, M., Aldini, G., & Facino, R. M. (2004) · Mass Spectrometry Reviews · doi:10.1002/mas.10076 · Cited by 176 · see citing works

Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment

Bermejo‐Bescós, P., Martín‐Aragón, S., Benedı́, J., Susín, C., Felici, E., Gil, P., Ribera, J. M., & Villar, Á. (2008) · Free Radical Research · doi:10.1080/10715760701861373 · Cited by 167 · see citing works

Biochemical markers related to Alzheimer’s dementia in serum and cerebrospinal fluid

Teunissen, C. E., de Vente, J., Steinbusch, H. W. M., & Bruijn, C. D. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00328-1 · Cited by 167 · see citing works

A detailed interpretation of OH radical footprints in a TBP-DNA complex reveals the role of dynamics in the mechanism of sequence-specific binding 1 1Edited by I. Tinoco

Pastor, N., Weinstein, H., Jamison, E., & Brenowitz, M. D. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4173 · Cited by 163 · see citing works

Peripheral Oxidative Damage in Mild Cognitive Impairment and Mild Alzheimer's Disease

Baldeiras, I., Santana, I. J., Proença, M. T., Garrucho, M. H., Pascoal, R., Rodrigues, A. P., Duro, D., & Oliveira, C. R. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15110 · Cited by 157 · see citing works

Peripheral F2‐isoprostanes and F4‐neuroprostanes are not increased in Alzheimer's disease

Montine, T. J., Quinn, J. F., Milatović, D., Silbert, L. C., Dang, T. N. T., Sanchez, S. C., Terry, E. S., Roberts, L. J., Kaye, J. A., & Morrow, J. D. (2002) · Annals of Neurology · doi:10.1002/ana.10272 · Cited by 156 · see citing works

Toward consensus in the analysis of urinary 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine as a noninvasive biomarker of oxidative stress

Evans, M. D., Oliński, R., Loft, S. H., & Cooke, M. S. (2009) · The FASEB Journal · doi:10.1096/fj.09-147124 · Cited by 145 · see citing works

Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia

Puertas, M. C., Martı́nez-Martos, J. M., Cobo, M., Carrera-González, M. P., Mayas, M. D., & Ramı́rez-Expósito, M. J. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.05.019 · Cited by 140 · see citing works

High sensitivity enzyme-linked immunosorbent assay (ELISA) method for measuring protein carbonyl in samples with low amounts of protein

Alamdari, D. H., Kostidou, E., Paletas, K., Sarigianni, M., Konstas, A. G. P., KARAPIPERIDOU, A., & Koliakos, G. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.06.023 · Cited by 138 · see citing works

Oxidative Stress Mediated Mitochondrial and Vascular Lesions as Markers in the Pathogenesis of Alzheimer Disease

Aliev, G., Priyadarshini, M., Reddy, V., Grieg, N. H., Kaminsky, Y., Cacabelos, R., Ashraf, G., Jabir, N. R., Kamal, M. A., Nikolenko, V. N., et al. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131227161303 · Cited by 138 · see citing works

Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease

Polidori, M. C., & Mecocci, P. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4608 · Cited by 137 · see citing works

Pathophysiology of Neuronal Energy Crisis in Alzheimer’s Disease

de la Torre, J. C. (2008) · Neurodegenerative Diseases · doi:10.1159/000113681 · Cited by 134 · see citing works

Mitochondrial dysfunction and Alzheimer's disease: role of amyloid‐β peptide alcohol dehydrogenase (ABAD)

Yan, S. D., & Stern, D. M. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00427.x · Cited by 131 · see citing works

Nrf2 activation as target to implement therapeutic treatments

Bocci, V. A., & Valacchi, G. (2015) · Frontiers in Chemistry · doi:10.3389/fchem.2015.00004 · Cited by 130 · see citing works

Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer’s disease

Abe, T., Tohgi, H., Isobe, C., Murata, T., & Sato, C. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10349 · Cited by 124 · see citing works

Measurement of F2- isoprostanes and isofurans using gas chromatography–mass spectrometry

Milne, G. L., Gao, B., Terry, E. S., Zackert, W. E., & Sanchez, S. C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.030 · Cited by 122 · see citing works

Measurement of HNE-protein adducts in human plasma and serum by ELISA—Comparison of two primary antibodies

Weber, D., Milković, L., Bennett, S. J., Griffiths, H. R., Žarković, N., & Grune, T. (2013) · Redox Biology · doi:10.1016/j.redox.2013.01.012 · Cited by 121 · see citing works

Vitamin E for Alzheimer's dementia and mild cognitive impairment

Farina, N., Isaac, M. G. E. K. N., Clark, A. R., Rusted, J. M., & Tabet, N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002854.pub3 · Cited by 120 · see citing works

Lipid peroxidation up‐regulates BACE1 expression in vivo : a possible early event of amyloidogenesis in Alzheimer’s disease

Chen, L., Na, R., Gu, M., Richardson, A. G., & Ran, Q. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05603.x · Cited by 119 · see citing works

Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment

Rukhsana Sultana, A., & Butterfield, D. A. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9241-7 · Cited by 108 · see citing works

Protein oxidative modifications in the ageing brain: Consequence for the onset of neurodegenerative disease

Grimm, S., Höhn, A., Davies, K. J. A., & Grune, T. (2010) · Free Radical Research · doi:10.3109/10715762.2010.512040 · Cited by 108 · see citing works

Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease

Du, Y., Wooten, M. C., Gearing, M., & Wooten, M. W. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.11.003 · Cited by 104 · see citing works

Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia

Cervellati, C., Romani, A., Seripa, D., Cremonini, E., Bosi, C., Magon, S., Passaro, A., Bergamini, C. M., Pilotto, A., & Zuliani, G. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.11.041 · Cited by 101 · see citing works

Use of Electron Paramagnetic Resonance Spectroscopy to Evaluate the Redox State In Vivo

Swartz, H. M., Khan, N. I., & Khramtsov, V. V. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1718 · Cited by 99 · see citing works

Brain Clearance of Alzheimer's Amyloid-β40 in the Squirrel Monkey: A SPECT Study in a Primate Model of Cerebral Amyloid Angiopathy

Bading, J., Yamada, S., Mackic, J., Kirkman, L., Miller, C., Calero, M., Ghiso, J., Frangione, B., & Zlokovic, B. (2002) · Journal of drug targeting (Print) · doi:10.1080/10611860290031831 · Cited by 89 · see citing works

Blood markers of oxidative stress in A lzheimer's disease

Skoumalová, A., & Hort, J. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01585.x · Cited by 87 · see citing works

Enhanced brain levels of 8,12- <i>iso</i> -iPF _2α -VI differentiate AD from frontotemporal dementia

Yao, Y., Zhukareva, V., Sung, S., Clark, C. M., Rokach, J., Lee, V. M.-Y., Trojanowski, J. Q., & Praticò, D. (2003) · Neurology · doi:10.1212/01.wnl.0000070185.02546.5d · Cited by 86 · see citing works

Semiautomated Method for Determination of Serum Paraoxonase Activity Using Paraoxon as Substrate

Charlton-Menys, V., Liu, Y., & Durrington, P. N. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.063412 · Cited by 81 · see citing works

Increased Cerebrospinal Fluid F2-Isoprostanes are Associated with Aging and Latent Alzheimer’s Disease as Identified by Biomarkers

Montine, T. J., Peskind, E. R., Quinn, J. F., Wilson, A. M., Montine, K. S., & Galasko, D. R. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8126-6 · Cited by 77 · see citing works

The polymorphic paraoxonase/arylesterase isozymes of human serum.

Bn, L. D., & Hw, E. (1984) · PubMed · Cited by 71 · see citing works

Systemic Oxidative Stress Associated with the Neurological Diseases of Aging

Serra, J. A., Domínguez, R. O., Marschoff, E. R., Guareschi, E. M., Famulari, A. L., & BOVERIS, A. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9997-5 · Cited by 70 · see citing works

Systemic Oxidative Stress in Older Patients with Mild Cognitive Impairment or Late Onset Alzheimer's Disease

Cervellati, C., Cremonini, E., Bosi, C., Magon, S., Zurlo, A., Bergamini, C. M., & Zuliani, G. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310040003 · Cited by 70 · see citing works

Neurotoxicity of reactive aldehydes: The concept of “aldehyde load” as demonstrated by neuroprotection with hydroxylamines

Wood, P. L., Khan, M. A., Kulow, S. R., Mahmood, S. A., & Moskal, J. R. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.038 · Cited by 69 · see citing works

Circulating biomarkers of protein oxidation for Alzheimer disease: Expectations within limits

Domenico, F. D., Coccia, R., Butterfield, D. A., & Marzia Perluigi, A. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.10.001 · Cited by 67 · see citing works

A polymorphism in SOD2 is associated with development of Alzheimer’s disease

Wiener, H. W., Perry, R. T., Chen, Z., Harrell, L. E., & Go, R. C. P. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00308.x · Cited by 66 · see citing works

Systemic Oxidative Stress and Conversion to Dementia of Elderly Patients with Mild Cognitive Impairment

Cervellati, C., Romani, A., Seripa, D., Cremonini, E., Bosi, C., Magon, S., Bergamini, C. M., Valacchi, G., Pilotto, A., & Zuliani, G. (2014) · BioMed Research International · doi:10.1155/2014/309507 · Cited by 63 · see citing works

Link between Cancer and Alzheimer Disease via Oxidative Stress Induced by Nitric Oxide-Dependent Mitochondrial DNA Overproliferation and Deletion

Aliev, G. M., Obrenovich, M. E., Tabrez, S. S. M., Jabir, N. R., Reddy, V. P., Li, Y., Burnstock, G., Cacabelos, R., & Kamal, M. A. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/962984 · Cited by 62 · see citing works

Paraoxonase activity and dementia

Wehr, H., Bednarska‐Makaruk, M., Graban, A., et al. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.317 · Cited by 61 · see citing works

The Oxidative Burst and Related Phenomena in Mouse Macrophages Elicited by Different Sterile Inflammatory Stimuli

Keisari, Y., Braun, L., & Flescher, E. (1983) · Immunobiology · doi:10.1016/s0171-2985(83)80048-5 · Cited by 60 · see citing works

Urinary 8-hydroxy-2′-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer’s disease

Zengi, O., Karakaş, A., Ergün, U., Şeneş, M., İnan, L. E., & Yücel, D. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.792 · Cited by 60 · see citing works

Metalloproteinase’s Activity and Oxidative Stress in Mild Cognitive Impairment and Alzheimer’s Disease

Martín‐Aragón, S., Bermejo‐Bescós, P., Benedı́, J., Felici, E., Gil, P., Ribera, J. M., & Villar, Á. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9789-3 · Cited by 56 · see citing works

PON1 and Oxidative Stress in Human Sepsis and an Animal Model of Sepsis

Draganov, D. I., Teiber, J. F., Watson, C., et al. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-60761-350-3_9 · Cited by 54 · see citing works

The Serum Protein and Lipid Oxidation Marker Levels in Alzheimers Disease and Effects of Cholinesterase Inhibitors and Antipsychotic Drugs Therapy

Sinem, F., Konukoğlu, D., Gokhan, E., Melda, B., Orhan, Y., & Filiz, M. (2010) · Current Alzheimer Research · doi:10.2174/156720510791383822 · Cited by 54 · see citing works

Expression and Polymorphisms of Gene 8-Oxoguanine Glycosylase 1 and the Level of Oxidative DNA Damage in Peripheral Blood Lymphocytes of Patients with Alzheimer's Disease

Dorszewska, J., Kempisty, B., Jaroszewska-Kolecka, J., Różycka, A., Florczak, J., Lianeri, M., Jagodziński, P. P., & Kozubski, W. P. (2009) · DNA and Cell Biology · doi:10.1089/dna.2009.0926 · Cited by 52 · see citing works

Pathogenesis of Alzheimer Disease: Role of Oxidative Stress, Amyloid-β Peptides, Systemic Ammonia and Erythrocyte Energy Metabolism

Kosenko, E. A., Solomadin, I., Tikhonova, L. A., Reddy, V. P., Aliev, G. M., & Kaminsky, Y. G. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660130 · Cited by 50 · see citing works

Expression of 8-oxoguanine DNA glycosylase 1 (OGG1) and the level of p53 and TNF-αlpha proteins in peripheral lymphocytes of patients with Alzheimer's disease.

Dezor, M., Dorszewska, J., Florczak, J., Kempisty, B., Jaroszewska-Kolecka, J., Różycka, A., Półrolniczak, A., Bugaj, R., Jagodziński, P. P., & Kozubski, W. P. (2011) · PubMed · Cited by 49 · see citing works

Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey

Aybek, H., Ercan, F., Aslan, D., & Şahiner, T. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.09.005 · Cited by 48 · see citing works

Age-Related Defects in Erythrocyte 2,3-Diphosphoglycerate Metabolism in Dementia

Kaminsky, Y. G. (2013) · Aging and Disease · doi:10.14336/ad.2013.0400244 · Cited by 45 · see citing works

Biomarkers of oxidative stress study VI. Endogenous plasma antioxidants fail as useful biomarkers of endotoxin-induced oxidative stress

Kadiiska, M. B., Peddada, S. D., Herbert, R. A., Basu, S., Hensley, K., Jones, D. P., Hatch, G. E., & Mason, R. P. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.01.006 · Cited by 42 · see citing works

Antioxidant Status and Energy State of Erythrocytes in Alzheimer Dementia: Probing for Markers

Kosenko, E. A., Aliev, G. M., Tikhonova, L. A., Li, Y., Poghosyan, A. C., & Kaminsky, Y. G. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311201070926 · Cited by 40 · see citing works

PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer’s disease or vascular dementia

Cervellati, C., Romani, A., Bergamini, C. M., Bosi, C., Sanz, J. M., Passaro, A., & Zuliani, G. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0803 · Cited by 38 · see citing works

Increased low-density lipoprotein oxidation, but not total plasma protein oxidation, in Alzheimer's disease

Aldred, S., Bennett, S. J., & Mecocci, P. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.08.021 · Cited by 37 · see citing works

Novel serum paraoxonase activity assays are associated with coronary artery disease

Martinelli, N., Girelli, D., Olivieri, O., Guarini, P., Bassi, A., Trabetti, E., Friso, S., Pizzolo, F., Bozzini, C., Tenuti, I., et al. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.108 · Cited by 33 · see citing works

Inability of Plasma and Urine F2A-Isoprostane Levels to Differentiate Mild Cognitive Impairment from Alzheimer’s Disease

Mufson, E. J., & Leurgans, S. E. (2010) · Neurodegenerative Diseases · doi:10.1159/000289224 · Cited by 33 · see citing works

Original article Paraoxonase 1 (PON1) gene -108C>T and p.Q192R polymorphisms and arylesterase activity of the enzyme in patients with dementia

Bednarska‐Makaruk, M., Krzywkowski, T., Graban, A., et al. (2013) · Folia Neuropathologica · doi:10.5114/fn.2013.35953 · Cited by 33 · see citing works

Resveratrol prevents cigarette smoke-induced keratinocytes damage

Sticozzi, C., Cervellati, F., Mureșan, X. M., Cervellati, C., & Valacchi, G. (2014) · Food & Function · doi:10.1039/c4fo00407h · Cited by 30 · see citing works

Lack of an association between Paraoxonase 1 gene polymorphisms (Q192R, L55M) and Alzheimer's disease: A meta-analysis

., Y. P., Zhang, L., Chang, K., Li, B., Guo, L., Fang, C., Gao, C., Wang, J., Xiang, J., & Li, J. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.06.071 · Cited by 28 · see citing works

Oxidative stress status: OSS, BOSS, and “wild bill” donovan

Pryor, W. A. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00213-0 · Cited by 18 · see citing works

Erythrocyte Membrane Stability to Hydrogen Peroxide is Decreased in Alzheimer Disease

Gîlcă, M., Lixandru, D., Gaman, L. E., et al. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000026 · Cited by 12 · see citing works

Waist circumference and dual-energy X-ray absorptiometry measures of overall and central obesity are similarly associated with systemic oxidative stress in women

Cervellati, C., Bonaccorsi, G., Cremonini, E., Romani, A., Castaldini, C., Ferrazzini, S., Giganti, M., Fila, E., Massari, L., & Bergamini, C. M. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2013.860618 · Cited by 10 · see citing works

Accumulation of central fat correlates with an adverse oxidative balance in non-obese postmenopausal women

Cervellati, C., Bonaccorsi, G., Cremonini, E., Romani, A., Fila, E., Castaldini, C., Ferrazzini, S., Massari, L., Squerzanti, M., Sticozzi, C., et al. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.831829 · Cited by 7 · see citing works

Untitled work

Price (1999) · doi:10.1002/1531-8249(199903)45:3

Untitled work

(2000) · doi:10.1002/1531-8249(200011)48:5

Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial

Akbari, E., Asemi, Z., Daneshvar Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O. R., Hamidi, G. A., & Salami, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00256 · Cited by 946 · see citing works

Brain Oxidative Stress in Animal Models of Accelerated Aging and the Age-related Neurodegenerative Disorders, Alzheimers Disease and Huntingtons Disease

Butterfield, D. A., Howard, B. J., & LaFontaine, M. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013373048 · Cited by 134 · see citing works

Oxidative Stress in Alzheimer’s Disease: Why Did Antioxidant Therapy Fail?

Persson, T., Popescu, B. O., & Cedazo-Mı́nguez, Á. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/427318 · Cited by 318 · see citing works

Oxidative Stress in Alzheimer’s Disease: A Critical Appraisal of the Causes and the Consequences

Chang, J., Siedlak, S. L., Moreira, P. I., Nunomura, A., Castellani, R. J., Smith, M. A., Zhu, X., Perry, G. L., & Casadesús, G. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-956-7_9 · Cited by 4 · see citing works

Alzheimer Disease and Oxidative Stress

Perry, G., Cash, A. D., & Smith, M. A. (2002) · BioMed Research International · doi:10.1155/s1110724302203010 · Cited by 455 · see citing works

The Potential Application of Antioxidant Agents in Alzheimer Disease Therapeutics

Moreira, P. I., Smith, M. A., Zhu, X., Nunomura, A., & Perry, G. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-71522-3_12